Q: How many years does it take for an Aveir VR LP to cause heart failure?
Short answer: there isn’t a set number of years — and for many people it never happens. When heart‑failure symptoms do occur after a ventricular pacemaker, it’s usually from “pacemaker‑induced cardiomyopathy” (PICM). The key driver is how much right‑ventricular pacing your heart receives over time, not the brand/model alone.
Why timing varies
- Pacing burden matters most. Heart‑failure risk rises as the percentage of time the device paces the right ventricle increases (for example, prolonged pacing >~20–40% can be more concerning).
- Onset window. When PICM happens, reports show it can appear within months to a few years. Some cohorts (largely with similar leadless RV devices) have observed single‑digit to low‑teens percentages of patients developing HF or LV dysfunction over ~1–3 years, highly dependent on pacing burden and patient factors.
- Aveir‑specific data are still maturing. Published Aveir VR studies have emphasized implant and short‑term performance; robust long‑term “time‑to‑HF” figures unique to Aveir VR have not yet been established.
What lowers the risk
- Minimize unnecessary RV pacing via device programming, when clinically appropriate.
- Aim for physiologic activation (narrower paced QRS, septal/non‑apical positions when feasible; in some cases consider AV‑synchronous or conduction‑system pacing strategies if indicated).
- Monitor proactively: baseline and follow‑up echocardiograms (e.g., at 6–12 months if the pacing percentage is high) to catch early LV function changes. Report new shortness of breath, fatigue, ankle swelling, or reduced exercise tolerance promptly.
If this is about you: Ask your cardiologist for your device’s ventricular pacing percentage, the paced QRS width, and the follow‑up echo plan — those are far more predictive than the calendar.